4-phenyl-1-prop-2-ynoyl-piperidine-4-carboxylic acid

ID: ALA5198420

PubChem CID: 54982791

Max Phase: Preclinical

Molecular Formula: C15H15NO3

Molecular Weight: 257.29

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CC(=O)N1CCC(C(=O)O)(c2ccccc2)CC1

Standard InChI:  InChI=1S/C15H15NO3/c1-2-13(17)16-10-8-15(9-11-16,14(18)19)12-6-4-3-5-7-12/h1,3-7H,8-11H2,(H,18,19)

Standard InChI Key:  HLACEKKLBLLSLE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.7145    0.2072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0001    0.6197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7142    0.2072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7142   -0.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0001   -1.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145   -0.6177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4287   -1.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4287   -1.8547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4284    0.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4287    1.4443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1411    1.8547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8555    1.4423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8571    0.6217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1457    0.2054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7142    1.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0001    1.4442    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1265    1.7461    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1429   -0.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8571   -0.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  6  7  1  0
  7  8  2  0
  9  3  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
 13 12  1  0
  9 14  1  0
 14 13  2  0
  3 15  1  0
 15 16  1  0
 15 17  2  0
  7 18  1  0
 18 19  3  0
M  END

Alternative Forms

Associated Targets(Human)

KMT2A Tchem Histone-lysine N-methyltransferase MLL (17327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 257.29Molecular Weight (Monoisotopic): 257.1052AlogP: 1.26#Rotatable Bonds: 2
Polar Surface Area: 57.61Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.98CX Basic pKa: CX LogP: 1.59CX LogD: -1.59
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.81Np Likeness Score: -0.28

References

1. Kalmode HP, Podsiadly I, Kabra A, Boulton A, Reddy P, Gao Y, Li C, Bushweller JH..  (2022)  Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation.,  13  (8.0): [PMID:35978680] [10.1021/acsmedchemlett.2c00198]
2. Getlik, Matthäus M and 17 more authors.  2016-03-24  Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1).  [PMID:26958703]

Source